Regulatory Information | Date |
EUA Amendment of SARS-CoV-2 Protein nanoparticle Vaccine [Covovax] | 14 February 2023 |
Product Information |
For more information on reporting side effects, click here.
Civic Drive Filinvest Corporate City
(02) 8857-1900
local 1000
(02) 8842-5635
Copyright © 2023. All Rights Reserved.